Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 6 studies | 69% ± 17% | |
| fibroblast | 4 studies | 38% ± 14% | |
| GABAergic neuron | 4 studies | 45% ± 16% | |
| glutamatergic neuron | 4 studies | 42% ± 16% | |
| adipocyte | 3 studies | 20% ± 3% | |
| Mueller cell | 3 studies | 30% ± 6% | |
| interneuron | 3 studies | 50% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 83% | 46.51 | 380 / 459 | 47% | 6.11 | 522 / 1118 |
| kidney | 70% | 57.79 | 62 / 89 | 47% | 2.41 | 421 / 901 |
| thymus | 93% | 52.41 | 605 / 653 | 21% | 0.57 | 125 / 605 |
| brain | 77% | 37.23 | 2032 / 2642 | 27% | 0.84 | 187 / 705 |
| heart | 100% | 4555.25 | 861 / 861 | 0% | 0 | 0 / 0 |
| lung | 80% | 44.88 | 464 / 578 | 19% | 0.46 | 223 / 1155 |
| blood vessel | 93% | 129.41 | 1239 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 90% | 50.61 | 216 / 241 | 0% | 0 | 0 / 0 |
| muscle | 87% | 83.36 | 702 / 803 | 0% | 0 | 0 / 0 |
| esophagus | 73% | 50.84 | 1048 / 1445 | 14% | 0.22 | 26 / 183 |
| ovary | 61% | 19.71 | 110 / 180 | 25% | 0.43 | 106 / 430 |
| adipose | 81% | 66.06 | 972 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 71% | 32.24 | 689 / 966 | 4% | 0.29 | 21 / 527 |
| bladder | 67% | 20.14 | 14 / 21 | 7% | 0.13 | 34 / 504 |
| uterus | 59% | 18.84 | 100 / 170 | 8% | 0.35 | 37 / 459 |
| prostate | 57% | 26.53 | 140 / 245 | 1% | 0.01 | 3 / 502 |
| skin | 44% | 22.18 | 796 / 1809 | 12% | 0.34 | 57 / 472 |
| pancreas | 30% | 8.11 | 98 / 328 | 16% | 0.24 | 29 / 178 |
| stomach | 39% | 14.25 | 140 / 359 | 5% | 0.08 | 15 / 286 |
| adrenal gland | 14% | 4.08 | 35 / 258 | 16% | 0.63 | 36 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 28% | 1.21 | 8 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.15 | 4 / 45 |
| peripheral blood | 8% | 2.82 | 73 / 929 | 0% | 0 | 0 / 0 |
| liver | 0% | 0.11 | 1 / 226 | 2% | 0.09 | 10 / 406 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.05 | 1 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042744 | Biological process | hydrogen peroxide catabolic process |
| GO_0098869 | Biological process | cellular oxidant detoxification |
| GO_0006979 | Biological process | response to oxidative stress |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004601 | Molecular function | peroxidase activity |
| GO_0140825 | Molecular function | lactoperoxidase activity |
| GO_0020037 | Molecular function | heme binding |
| GO_0004519 | Molecular function | endonuclease activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | PXDNL |
| Protein name | Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2) Peroxidasin like |
| Synonyms | VPO2 |
| Description | FUNCTION: Probable oxidoreductase (Probable). Lacks peroxidase activity . Inhibits the peroxidase activity of PXDN through its interaction . .; FUNCTION: [Isoform PMR1]: Endonuclease selectively degrading some target mRNAs while they are engaged by translating ribosomes, among which albumin and beta-globin mRNAs. . |
| Accessions | ENST00000356297.5 [A1KZ92-1] A1KZ92 ENST00000522628.5 K4DIA6 H0YAV0 ENST00000522933.5 |
